Rachelle Jacques
2023
In 2023, Rachelle Jacques earned a total compensation of $1.6M as Former President and Chief Executive Officer at Akari Therapeutics Plc, a 57% decrease compared to previous year.
Compensation breakdown
| Option Awards | $198,498 |
|---|---|
| Salary | $615,750 |
| Stock Awards | $729,393 |
| Other | $16,500 |
| Total | $1,560,141 |
Jacques received $729.4K in stock awards, accounting for 47% of the total pay in 2023.
Jacques also received $198.5K in option awards, $615.8K in salary and $16.5K in other compensation.
Rankings
In 2023, Rachelle Jacques' compensation ranked 752nd out of 2,918 executives tracked by ExecPay. In other words, Jacques earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 752 out of 2,918 | 74th |
Division Manufacturing | 437 out of 1,608 | 73rd |
Major group Chemicals And Allied Products | 298 out of 901 | 67th |
Industry group Drugs | 292 out of 864 | 66th |
Industry Pharmaceutical Preparations | 194 out of 622 | 69th |
Source: SEC filing on June 3, 2024.
Jacques' colleagues
We found two more compensation records of executives who worked with Rachelle Jacques at Akari Therapeutics Plc in 2023.